Radiofrequency ablation for cavernous lymphangiomas of the tongue and the oral cavity.

Radiofrequency ablation for cavernous lymphangiomas of the tongue and the oral cavity. - Radiofrequency ablation for cavernous lymphangiomas of the tongue and the oral cavity.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000007625

Enrollment

Registered

2012-04-01

Start date

2012-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cavernous lymphangiomas of the tongue and the oral cavity

Interventions

We perform radiofrequency ablation for cavernous lymphangioma of the tongue and the oral cavity.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Tumor located at pucturable site 2. Regardless of age or past treatment 3. Regardless of the other site of lymphangioma 4. Regardless of the component of hemangioma 5. Written informed consent

Exclusion criteria

Exclusion criteria: 1. With Complications which have serious effect on the ablation 2. Tumor located at unpuncturable site 3. Tumor located near the important nerves or vessels 4. Inappropriate patient for this study judged by the investigators

Design outcomes

Primary

Measure	Time frame
subjective symptom gross pathology size of the tumor	—

Countries

Japan

Contacts

Public ContactTakanori Oyama

Okayama university hospital Department of Pediatric Surgery

oyama@cc.okayama-u.ac.jp+81-86-223-7151

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026